M. Schenker

机构：University of Medicine and Pharmacy of Craiova, Spitalul Clinic de Urgenta Sfantul Ioan

发表论文 3 篇 · 总被引 34 次 · h-index 2

代表论文

• Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA (2025 · ESMO Open · 被引 32)
• 2MO First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) in metastatic non-small cell lung cancer (mNSCLC): Clinical outcomes and biomarker analyses from CheckMate 592 (2022 · Immuno-Oncology Technology · 被引 2)
• 1102P Contribution of bevacizumab (bev) use to safety outcomes in FIRST/ENGOT-OV44 (2025 · Annals of Oncology)